insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

Retraction notice to "SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway" [Heliyon 10 (2024) e24394].

1/5 보강
Heliyon 📖 저널 OA 100% 2021: 1/1 OA 2022: 5/5 OA 2023: 21/21 OA 2024: 91/91 OA 2025: 28/28 OA 2021~2025 2025 Vol.11(17) p. e44173
Retraction 확인
출처
PubMed DOI PMC

Wang XT, Li L, Zhu Z, Huang YL, Chen HH, Shi ZY

📖 무료 전문 🟢 PMC 전문 PMC12717578
PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓
📝 환자 설명용 한 줄

[This retracts the article DOI: 10.1016/j.heliyon.2024.e24394.].

이 논문을 인용하기

↓ .bib ↓ .ris
APA Wang XT, Li L, et al. (2025). Retraction notice to "SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway" [Heliyon 10 (2024) e24394].. Heliyon, 11(17), e44173. https://doi.org/10.1016/j.heliyon.2025.e44173
MLA Wang XT, et al.. "Retraction notice to "SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway" [Heliyon 10 (2024) e24394].." Heliyon, vol. 11, no. 17, 2025, pp. e44173.
PMID 41497854 ↗
DOI 10.1016/j.heliyon.2025.e44173

Abstract

[This retracts the article DOI: 10.1016/j.heliyon.2024.e24394.].
🟢 PMC 전문 열기